Neurogene (NGNE) Long-Term Debt Repayments (2014 - 2020)
Neurogene (NGNE) reported Long-Term Debt Repayments of $2000.0 for Q1 2020, little changed on a YoY basis from $2000.0 in Q2 2019, and little changed quarter-over-quarter from $2000.0 in Q4 2019.
Neurogene (NGNE) Long-Term Debt Repayments (2014 - 2020) Analysis & Trends
Neurogene has reported Long-Term Debt Repayments for 6 years, with the latest figure at $2000.0 in Q1 2020.
- For the quarter ending Q1 2020, Long-Term Debt Repayments changed 0.0% year-over-year to $2000.0; the trailing twelve-month figure through Mar 2020 stood at $9000.0 (down 70.0% YoY), and the FY2019 full-year result was $9000.0, down 71.88% from the prior year.
- Long-Term Debt Repayments for Q1 2020 stood at $2000.0, roughly flat from $2000.0 in the prior quarter.
- The five-year high for Long-Term Debt Repayments was $22000.0 in Q3 2018, with the low at $1000.0 in Q3 2016.
- Historically, Long-Term Debt Repayments has averaged $4066.7 across 5 years, with a median of $3000.0 in 2017.
- Annual changes were most pronounced in 2018 — Long-Term Debt Repayments soared 450.0% — and 2019, when it plunged 86.36%.
- Neurogene's Long-Term Debt Repayments stood at $2000.0 in 2016, then surged by 100.0% to $4000.0 in 2017, then slumped by 50.0% to $2000.0 in 2018, then changed by 0.0% to $2000.0 in 2019, then changed by 0.0% to $2000.0 in 2020.
- The last three Long-Term Debt Repayments figures came in at $2000.0 (Q1 2020), $2000.0 (Q4 2019), and $3000.0 (Q3 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -21,671.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Neurogene | 216.17 Mn | 216.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 2,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Mar 31, 2019 | 2,000.00 |
| Mar 31, 2019 | 2,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Sep 30, 2018 | 22,000.00 |
| Sep 30, 2018 | 22,000.00 |
| Jun 30, 2018 | 4,000.00 |
| Jun 30, 2018 | 4,000.00 |
| Mar 31, 2018 | 4,000.00 |
| Mar 31, 2018 | 4,000.00 |
| Dec 31, 2017 | 4,000.00 |
| Dec 31, 2017 | 4,000.00 |